Catecholamine metabolism during oral administration of levodopa.
D000368:Aged; D002395:Catecholamines / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism / Q000652:urine; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism*; D010648:Phenylacetates / Q000134:cerebrospinal fluid / Q000378:metabolism; D014642:Vanilmandelic Acid / Q000378:metabolism
D002395:Catecholamines; D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine